You have 5 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkins lymphoma

Showing 26 - 50 of 5,128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated
  • Double Cord Blood Transplant
  • +8 more
  • TXA127 300 mcg/kg/day
  • TXA127 1000 mcg/kg/day
  • Houston, Texas
    MD Anderson Cancer Center
Dec 7, 2020

Acute Myeloid Leukemia, Lymphoblastic Leukemia, Acute Leukemia Trial in Chicago (IM-TMI (3Gy), IM-TMI (6Gy), IM-TMI (9Gy))

Completed
Has Results
  • Acute Myeloid Leukemia
  • +4 more
  • IM-TMI (3Gy)
  • +3 more
  • Chicago, Illinois
    University of Illinois at Chicago
May 18, 2021

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

Active, not recruiting
Has Results
  • Acute Myelogenous Leukemia
  • +10 more
  • Atlanta, Georgia
  • +2 more
Feb 9, 2022

Non Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia Trial in France, United Kingdom (Tirabrutinib)

Completed
Has Results
  • Non Hodgkins Lymphoma
  • Chronic Lymphocytic Leukaemia
  • Lille, France
  • +5 more
Feb 22, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Jan 25, 2022

Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas Trial in Philadelphia (CART-19)

Completed
Has Results
  • Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas
  • CART-19
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 1, 2020

B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in France, United States (XmAb13676)

Recruiting
  • B-cell Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • XmAb13676
  • La Jolla, California
  • +21 more
Oct 20, 2021

Lymphoma Trial in Rochester (Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD))

Completed
Has Results
  • Lymphoma
  • Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD)
  • Rochester, Minnesota
    Mayo Clinic
Jan 6, 2020

Hodgkin Lymphoma Trial in Saint-Petersburg (Nivolumab 40 mg in 4 ml Injection)

Completed
  • Hodgkin Lymphoma
  • Nivolumab 40 mg in 4 ml Injection
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Jan 22, 2020

Classical Hodgkin's Lymphoma Trial in Worldwide (Panobinostat)

Completed
Has Results
  • Classical Hodgkin's Lymphoma
  • Duarte, California
  • +45 more
Jul 26, 2021

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • +9 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 4, 2021

DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

Terminated
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
Jul 20, 2022

Non Hodgkin Lymphoma, Follicular Lymphoma, Indolent Lymphoma Trial in Miami, Baltimore, Milwaukee (Zydelig)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • +8 more
  • Miami, Florida
  • +2 more
Apr 21, 2022

Non-Hodgkins Lymphoma, Solid Tumor Trial in Vancouver, Ottawa (Aurora kinase inhibitor AT9283)

Completed
  • Non-Hodgkins Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Aurora kinase inhibitor AT9283
  • Vancouver, British Columbia, Canada
  • +1 more
Apr 6, 2020

Hodgkins Lymphoma Trial in Italy, United Kingdom, United States (Avelumab)

Terminated
Has Results
  • Hodgkins Lymphoma
  • Duarte, California
  • +12 more
Apr 3, 2020

Advanced Solid Tumors, Advanced B-cell NHL Trial in Worldwide (Urelumab, Nivolumab)

Terminated
Has Results
  • Advanced Solid Tumors
  • Advanced B-cell NHL
  • Urelumab
  • Nivolumab
  • Palo Alto, California
  • +16 more
Sep 10, 2020

Leukemia, Non-Hodgkins Lymphoma, Hodgkins Lymphoma Trial run by the NCI (EPOCH-F/R, FLAG, Transplant Preparative Regimen

Terminated
  • Leukemia
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Prostate Cancer, Non-Hodgkins Lymphoma Trial in Los Angeles, San Antonio, Sutton (SGI-1776)

Terminated
  • Prostate Cancer
  • Non-Hodgkins Lymphoma
  • Los Angeles, California
  • +2 more
Jan 13, 2020

Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Worldwide (Camidanlumab Tesirine)

Active, not recruiting
  • Relapsed Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Camidanlumab Tesirine
  • Scottsdale, Arizona
  • +72 more
Dec 15, 2022

Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Maywood (Total body irradiation)

Completed
  • Relapsed Non Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Total body irradiation
  • Maywood, Illinois
    Patrick Stiff, MD
Aug 19, 2019

Lymphoma, Non-Hodgkin Trial in Germany, Puerto Rico, United States (Lenalidomide, Rituximab)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Tucson, Arizona
  • +114 more
Jan 11, 2023

Cancer, Immune-related Adverse Event Trial in Durham (Medical chart review)

Enrolling by invitation
  • Cancer
  • Immune-related Adverse Event
  • Medical chart review
  • Durham, North Carolina
    Duke University Medical Center
Oct 20, 2023

Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +8 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Hodgkin's Lymphoma Trial in United States (TGR-1202 + brentuximab vedotin)

Completed
  • Hodgkin's Lymphoma
  • TGR-1202 + brentuximab vedotin
  • Duarte, California
  • +3 more
Oct 1, 2019